Apollo Hospitals Enterprise Limited · NSE:APOLLOHOSP
Apollo Hospitals Enterprise — Q4 FY23 Earnings Presentation
25 slides from Apollo Hospitals Enterprise's earnings presentation, February 2025
Slide 1: Apollo Hospitals Enterprise Limited Earnings Update Q4 FY23
APOLLO HOSPITALS ENTERPRISE LIMITED Earnings Update Q4 FY23
Slide 2: Key Highlights
Key Highlights Highlights Financials Healthcare Services Diagnostics & Retail Digital Health Annexure Health & Pharmacy Distribution 2
Slide 3: Highlights
HIGHLIGHTS 3
Slide 4: Highlights FY23
Highlights FY23 Healthcare Revenue EBITDA Services 43 Owned 9,395 64% ` 86,768 Mio ` 21,331 Mio (Hospitals) ` 51,668 / day 540,881 + Owned & Occupancy Rev ARPOB1 In-patients 52% 24.6% Share 5 Managed Managed ` 53,232 / day Margin Hospitals Beds in Q423 ` 12,311 Mio ` 1,182 Mio Diagnostics & Rev 7% 9
Slide 5: Highlights Q4FY23
Highlights Q4FY23 Financial Performance Q4FY23 Healthcare Revenue EBITDA o Consolidated Revenues at `43,022 Mio for Q4FY23 growth of 21%. Services ` 21,946 Mio ` 5,347 Mio o Consolidated EBITDA before 247 operating cost at `7,056 Mio (Hospitals) Rev o 247 costs at `2,174 Mio including Non Cash ESOP
Slide 6: Financials: Consolidated
Financials Consolidated 6
Slide 7: Consolidated Financials Q4 FY23
Consolidated Financials Q4 FY23 (` mio) Digital Health Healthcare Diagnostics & ` Mio & Pharmacy Consol Note 1 : Services Retail Health Distribution Covid Vaccination revenues in Q4 FY22 Total Revenues 21,946 3,085 17,992 43,022 EBITDA (Post Ind AS 116) (Pre 24|7 Cost) 5,347 255 1,453 7,056 Hospital
Slide 8: Consolidated Financials FY23
Consolidated Financials FY23 (` mio) Digital Health Healthcare Diagnostics & Note 1 : ` Mio & Pharmacy Consol Services Retail Health Covid Vaccination revenues in FY22 Distribution Total Revenues 86,768 12,311 67,045 166,125 Hospitals : ` 3,217 mio EBITDA (Post Ind AS 116) (Pre 24|7 Cost) 21,331 1,1
Slide 9: Healthcare Services: Hospitals
Healthcare Services Hospitals Consolidated 9
Slide 10: Consolidated Healthcare Services Performance Q4FY23
Consolidated Healthcare Services Performance Q4FY23 (` mio) Healthcare Serv Healthcare Serv Healthcare Serv IP Volume grew by 16% from 115,902 in Q4FY22 to ` Mio Group (New & Group (Mature) Group 133,991 in Q4FY23. Others) No of Hospitals 29 14 43 Operating beds 5476 2384 7860 Revenue grew by 18% ex
Slide 11: Consolidated Healthcare Services Performance FY23
Consolidated Healthcare Services Performance FY23 (` mio) Healthcare Serv Healthcare Serv Healthcare Serv IP Volume grew by 18% from 460,152 in FY22 to ` Mio Group (New & Group (Mature) Group 540,881 in FY23. Others) No of Hospitals 29 14 43 Operating beds 5476 2384 7860 Revenue grew by 13%YoY exclu
Slide 12: Region wise Operational Parameters
Region wise Operational Parameters Tamilnadu Region AP, Telengana Region (Hyderabad Total (6) (2) (Chennai & others) (1) & others) Particulars FY 22 FY 23 yoy (%) FY 22 FY 23 yoy (%) FY 22 FY 23 yoy (%) FY23 ARPOB in Metro cities at No. of Operating beds 7,875 7,860 2,131 2,112 1,344 1,297 ` 61,129
Slide 13: Diagnostics & Retail Health
Diagnostics & Retail Health Apollo Health & Lifestyle Ltd 13
Slide 14: Executive Summary
Executive Summary ➢ Network grew by 37% in FY23 from 468 touchpoints in FY22 to 641 touchpoints in FY23 Primary ➢ Health checks and Consultations volumes grew by 50% and 30% respectively YoY in FY23 Care ➢ Focus on strengthening omni-channel service offerings for delivering continuum of care ➢ Diagn
Slide 15: Financial Performance Q4FY23
Financial Performance Q4FY23 (` mio) Q4 FY23 Clinics Diagnostics Sugar Dental Dialysis Cradles (IP) IVF Spectra (IP) Network 343 1,750 58 129 111 9 17 11 AHLL Core Revenues (excluding Covid Footfalls/Day* 2,833 12,410 444 226 1,749 48 36 65 Vaccination, Covid Testing and Gross ARPP (Rs.)* 1,844 795
Slide 16: Financial Performance FY23
Financial Performance FY23 (` mio) FY23 Clinics Diagnostics Sugar Dental Dialysis Cradles (IP) IVF Spectra (IP) Network 343 1,750 58 129 111 9 17 11 AHLL Core Revenues (excluding Covid Footfalls/Day* 4,920 12,154 714 316 1,649 47 33 72 Vaccination, Covid Testing and Isolation Gross ARPP (Rs.)* 1,510
Slide 17: Diagnostics: Key Parameters
Diagnostics : Key Parameters Gross Revenue (INR Mn)1 3,988 3,827 EBITDA* (INR Mn)2 Operational footprint 256 (as of Mar 31, 2023) 1,522 14% 16% ~200 7.5% Cities 3,571 1,087 1,040 940 1,031 5% 5% 287 presence 816 2,466 5% 118 15 413 99 24 173 148 922 916 1,016 675 717 39 50 51 Q4 FY22 Q1 FY23 Q2 FY23
Slide 18: Digital Health & Pharmacy Distribution
Digital Health & Pharmacy Distribution Apollo Health Co 18
Slide 19: India's Largest Omni-Channel Healthcare
India’s Largest Omni-Channel Healthcare Apollo HealthCo Ltd (AHL) Apollo 247 –Digital Platform Apollo Pharmacy Platform Added As at Mar 31, 2023 1,151 FY 23 ~25Mn+ ~7 Lakh ~6,000+ Closed 139 Doctors FY 23 Registrations Daily Active Users Chandigarh: 5 Net 1,012 Virtual Doctor Consultation Daily Cons
Slide 20: Health Co Financials Q4 FY23
Health Co Financials Q4 FY23 Online Pharmacy ` Mio Offline Pharmacy Distribution & Total Health o Q4 delivered GMV : Rs 593 cr (9% higher vs Q3’ FY23) Distribution Co Apollo 247 Total Revenues 15,452 2,539 17,992 o March run rate of ~56K/day transactions across Pharma, Diagnostics, EBITDA (Post Ind
Slide 21: Health Co Financials FY 23
Health Co Financials FY 23 Online Pharmacy Key milestones : Digital Business Offline Pharmacy Total Health ` Mio Distribution & Distribution Co o Digital platform delivered GMV : Rs 1,643 cr in FY 23, with YoY growth Apollo 247 of 266% over FY 22. New business segment IP/OP launched Total Revenues 5
Slide 22: Annexure
Annexure 22
Slide 23: Basis of Consolidation
Basis of Consolidation AHEL AHEL Standalone Hospitals (100% Ownership) Location Subsidiaries Location Description Ownership Chennai Main Chennai Material Subs ACI - Chennai Chennai Apollo Health Co limited India Digital Omni-Channel Healthcare services 100.00% Tondiarpet - Chennai Chennai Apollo Hea
Slide 24: Ind AS 116: Impact on P&L and Balance Sheet FY23
IND AS - 116 : Impact on P&L and Balance Sheet – FY23 ` Mio AHEL Standalone (post IND AS 116) AHEL Consolidated (post IND AS 116) Balance sheet Profit & Loss Balance sheet Profit & Loss Right of use 5,283 Revenue Right of use 12,317 Revenue Asset Asset Other 849 Other as of as of 1,973 expenses 31st
Slide 25: Thank you!
SS Wi Thank you!
Apollo Hospitals Enterprise — Q4 FY23 Earnings Presentation on 6ix